Skip to main content
Clinical Trials/NCT01698372
NCT01698372CompletedPhase 1

Negative Pressure Dressing to Decrease the Incidence of Leg Wound Complications After CABG

University of Calgary1 site in 1 country64 target enrollmentStarted: September 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
64
Locations
1
Primary Endpoint
Change from baseline ASEPSIS score of wound healing at 6 weeks.

Study Overview

Brief Summary

This study will test the effectiveness of negative pressure wound therapy (using the VAC Prevena device, KCI Canada Inc.) applied to the saphenous vein harvest site after Coronary Artery Bypass Grafting (CABG). When initiated immediately after surgery, this intervention may decrease the incidence of wound infection and non-infectious wound complications. It may decrease wound discomfort and improve mobility and functional recovery of the leg.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients presenting for elective or semi-elective isolated first-time CABG surgery with harvesting of the greater saphenous vein.
  • •Must be 18 years or older.
  • •Must live with one hour driving distance from Calgary.
  • •Must provide written consent.

Exclusion Criteria

  • •Previous CABG surgery or previous lower leg surgical intervention.
  • •In emergent need for surgery.
  • •Have severe peripheral vascular disease.
  • •Do not speak and read the English language.
  • •Have dialysis-dependent renal failure.
  • •Require chronic steroids.
  • •Unable to return to clinic for follow-up due to functional or cognitive impairment.

Arms & Interventions

Prevena device (Group A)

Experimental

Group A will have the VAC Prevena portable device applied to the saphenous vein harvest site after standard wound closure following coronary artery bypass surgery.

Intervention: Prevena device (Group A) (Device)

Conventional dressing (Group B)

No Intervention

Group B will have conventional dry dressing applied to the saphenous vein harvest site after standard wound closure following coronary artery bypass surgery.

Outcomes

Primary Outcomes

Change from baseline ASEPSIS score of wound healing at 6 weeks.

Time Frame: Baseline and 6 weeks

The ASEPSIS quantitative wound scoring method will be used to assess patients' leg wound healing after saphenous vein harvesting for coronary artery bypass surgery.

Secondary Outcomes

  • Total score of pain level.(Baseline and 6 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dr. Paul Fedak

Associate Professor

University of Calgary

Study Sites (1)

Loading locations...

Similar Trials

Negative Pressure Dressing After Saphenous... | Clinical Trial